Donaghy, Paul C. http://orcid.org/0000-0001-7195-4846
Firbank, Michael
Mitra, Dipayan
Petrides, George
Lloyd, Jim
Barnett, Nicola
Olsen, Kirsty
Thomas, Alan J.
O’Brien, John T.
Funding for this research was provided by:
NIHR Newcastle Biomedical Research Centre (BH120812)
Avid Radiopharmaceuticals
Article History
Received: 10 December 2019
Revised: 27 January 2020
Accepted: 27 January 2020
First Online: 4 February 2020
Compliance with ethical standards
:
: Dr. Donaghy reports grants from Alzheimer’s Research UK and Alzheimer’s Society. Dr. Firbank has nothing to disclose. Dr. Mitra reports a grant from the National Institute of Health Research. Dr. Lloyd has nothing to disclose. Dr. Petrides reports honoraria for educational presentations from GE Healthcare. Ms Barnett has nothing to disclose. Ms Olsen has nothing to disclose. Prof. Thomas reports grants from Alzheimer’s Research UK, Alzheimer’s Society, Economic and Social Research Council, Medical Research Council, National Institute of Health Research, Lewy Body Society and GE Healthcare. Prof. O’Brien reports grants from Alzheimer’s Research UK, Alzheimer’s Society, Medical Research Council and National Institute of Health Research; personal fees from TauRx, Eisai and Axon; honoraria from the British Association of Psychopharmacology; Royalties from Taylor and Francis.
: This study received ethical approval from the National Research Ethics Service Committee North East—Newcastle and North Tyneside 2 (13/NE/0064) and was carried out in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Participants with capacity gave their written informed consent to take part in the study. For those who lacked capacity, their participation in the study was discussed with a consultee in accordance with the Mental Capacity Act (UK).